Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Mark G. Roback etal 2006 USA | 225 patients children aged 4 months to 18yr presenting with orthopaedic injury, ASA1 and 2 receiving procedural sedation for orthopaedic reduction are randomised to receive either IV(1mg/kg) or IM(4mg/kg) ketamine | PRCT Level of Evidence 1b | Respiratory adverse events | 12/109 8.3% in IV group and 4 of 99 i;e 4% in IM group Odds Ratio 0.45 CI 95% | No blinding done in the study Difference in the adverse events is secondary to the dose or route of administration? Sample not large enough to show significant difference in the adverse events Study on only Orthopaedic procedures |
Vomiting | 20/109 (18.3%) in IV 35/99 (35.4%) in IM | ||||
Distress during the procedure(Mean pain score) | IM -0.34, IV-0.81, difference of 0.47 95% CI | ||||
Parental satisfaction | 93.6% IV group 89.9% IM group | ||||
Physician Satisfaction | 91.7% IV group 93.9% IM group | ||||
Length of sedation | Median IM 129min(55-365) Median IV 80min(27-210) P<0.01 | ||||
McCarty etal 2000 USA | 114 children(12 months to 12 yr) undergoing closed reduction of isolated fracture or dislocation 99 received 2mg/kg IV Ketamine and 4mg/kg in 15 patients | Prospective Case Series Level of Evidence 4 | Mean Duration of procedure | IV -7 min 48 sec(5-46 min) IM 19 min 42 sec(10-50min) | Small sample Randomisation not clear Study subjects having only one treatment module Adverse events not reported or compared between the groups |
Discharge time | IV-84 min(22-115) IM-90min(60-130) | ||||
Pain Score | IV-6.3 IM-6.5 | ||||
K C Ng etal Singapore 1999 | 500 paediatric patients given ketamine for conscious sedation either IM (3-4 mg/kg) or IV (1-2 mg/kg) together with atropine(0.02 mg/kg), with or without intravenous midazolam (0.05 mg/kg) | Retrospective case series review Level of Evidence-4 | Discharge from hospital | 480/500 (96% ) discharged safely , 11/500(2.2%) admitted because of Failure of manipulation and reduction,7/500 (1.4%) admitted because of other clinical indications,1/500(0.2%) admitted because of conscious sedation | Didn’t study the difference in the IV and IM group and any other adverse events during or after the procedure. This article was mainly to prove that ketamine was safe to be used in ED |
Stephen J Priestley etal 2001 Australia | Twenty-eight children aged 1.5–12 years were administered ketamine sedation prior to undergoing a painful procedure. Ketamine was administered either i.m. (dose 3–4 mg/kg) or i.v. (dose 1.00 –2.75 mg/kg) depending on physician preference.Midazolam (dose 0.02 mg/kg) and atropine (dose 0.02 mg/kg) were given as adjuncts in the majority of cases. | Case Control Study Level of Evidence 3b | Mean time to onset (min) | IV 2 min(1–4), IM 3.7 min(2–7) | Small sample Adverse events not documented. |
Mean length of procedure (min) | IV 12.4 min(2–26) IM 15.5 min(6–60) | ||||
Mean time to discharge (min) | IV 93.9 min(67–145) IM 112.3 min(78–180) | ||||
Steven M. Green, MD etal 2009 Feb USA | Pooled individual-patient data from 32 ED studies(24 prospective) where ketamine was used as procedural sedation in children and determine which clinical variables would predict airway and respiratory adverse events. ketamine technique variables chosen were route (IM/IV), initial dose (in mg/kg), total dose (in mg/kg), the presence or absence of coadministered anticholinergics (eg, atropine, glycopyrrolate), and the presence or absence of coadministered benzodiazepines (eg, midazolam, diazepam). patient variables chosen were age, ASA physical status and oropharyngeal procedural indication Route Intramuscular 2,604 Intravenous 5,678 | Metanalysis/Systematic review of different type of studies Level of Evidence 3a | airway/respiratory adverse events. | IV Realtive to IM Odds Ratio in Total Sample 1.38 (0.99–1.90) Prospective subset 1.12 (0.79–1.59) 95%CI | Heterogenicity of the studies and observational nature of the data. Under reporting of adverse events in the studies very less number of studies comparing IV to IM |
Apnea | IV Realtive to IM Odds Ratio in Total Sample 2.26 (0.85–5.99) Prospective Subset 1.48 (0.50–4.40) 95% CI | ||||
laryngospasm | IV route 10 of 22 patients(45.5%) |